Monday 22 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

UK Investor Show 2017 raises £14,500 for Woodlarks - so far! More to come

By ShareProphets | Saturday 15 April 2017


There are some people who think the stockmarket and shares business is like robbing a bank - all about making money however you go about it. But at a time of year when many of us think about a man who gave the ultimate gift, his life, for others we think that business should also be about giving. And that brings us to Woodlarks and the UK Investor Show. It started with Paul Scott who donated his, very small, speaker fee...

Well done Paul, not only the UK's top share blogger but a nice guy too.

And many of you dipped into your pockets to make a donation on the day. Nigel Wray wote a cheque for £5,000 and Tom Winnifrith for £3,000, money which was invested in two "golden shares" on behalf of Woodlarks. Nigel went for Franchise Brands (FRAN) and his £5,000 is now valued at £8,916. Tom went for Skinbiotherapreutics (SBTX) and his £3,000 is now £4,500.

So that means that, so far, Woodlarks is c£14,500 better off as a result of the show. But we are not finished yet. Neither share has been sold as both will, we think, deliver far greater gains before Woodlarks cashes out.

Woodlarks is not a fashionable charity. But it is one that Tom and Nigel have been supporting financially in various ways for sixteen years. And we know that many of you have too. But we are not finished yet...

Plans are already underway to raise even more in 2018 on April 21 at the UK Investor Show. Naturally we also expect both golden shares to make even more for Woodlarks. And perhaps you attended the show, but forgot to make a donation. If so it is not too late. Just go HERE

Filed under:

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.


Comments are turned off for this article.

Site by Everywhen